185 related articles for article (PubMed ID: 37669939)
1. Single cell multiomic analysis reveals diabetes-associated β-cell heterogeneity driven by HNF1A.
Weng C; Gu A; Zhang S; Lu L; Ke L; Gao P; Liu X; Wang Y; Hu P; Plummer D; MacDonald E; Zhang S; Xi J; Lai S; Leskov K; Yuan K; Jin F; Li Y
Nat Commun; 2023 Sep; 14(1):5400. PubMed ID: 37669939
[TBL] [Abstract][Full Text] [Related]
2. Integrating genetics with single-cell multiomic measurements across disease states identifies mechanisms of beta cell dysfunction in type 2 diabetes.
Wang G; Chiou J; Zeng C; Miller M; Matta I; Han JY; Kadakia N; Okino ML; Beebe E; Mallick M; Camunas-Soler J; Dos Santos T; Dai XQ; Ellis C; Hang Y; Kim SK; MacDonald PE; Kandeel FR; Preissl S; Gaulton KJ; Sander M
Nat Genet; 2023 Jun; 55(6):984-994. PubMed ID: 37231096
[TBL] [Abstract][Full Text] [Related]
3. Single-cell chromatin accessibility identifies pancreatic islet cell type- and state-specific regulatory programs of diabetes risk.
Chiou J; Zeng C; Cheng Z; Han JY; Schlichting M; Miller M; Mendez R; Huang S; Wang J; Sui Y; Deogaygay A; Okino ML; Qiu Y; Sun Y; Kudtarkar P; Fang R; Preissl S; Sander M; Gorkin DU; Gaulton KJ
Nat Genet; 2021 Apr; 53(4):455-466. PubMed ID: 33795864
[TBL] [Abstract][Full Text] [Related]
4. Effects of hepatocyte nuclear factor-1A and -4A on pancreatic stone protein/regenerating protein and C-reactive protein gene expression: implications for maturity-onset diabetes of the young.
Kyithar MP; Bonner C; Bacon S; Kilbride SM; Schmid J; Graf R; Prehn JH; Byrne MM
J Transl Med; 2013 Jun; 11():156. PubMed ID: 23803251
[TBL] [Abstract][Full Text] [Related]
5. Bone morphogenetic protein 3 controls insulin gene expression and is down-regulated in INS-1 cells inducibly expressing a hepatocyte nuclear factor 1A-maturity-onset diabetes of the young mutation.
Bonner C; Farrelly AM; Concannon CG; Dussmann H; Baquié M; Virard I; Wobser H; Kögel D; Wollheim CB; Rupnik M; Byrne MM; König HG; Prehn JH
J Biol Chem; 2011 Jul; 286(29):25719-28. PubMed ID: 21628466
[TBL] [Abstract][Full Text] [Related]
6. Characterization of beta cell and incretin function in patients with MODY1 (HNF4A MODY) and MODY3 (HNF1A MODY) in a Swedish patient collection.
Ekholm E; Shaat N; Holst JJ
Acta Diabetol; 2012 Oct; 49(5):349-54. PubMed ID: 21761282
[TBL] [Abstract][Full Text] [Related]
7. Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes.
Harries LW; Ellard S; Stride A; Morgan NG; Hattersley AT
Hum Mol Genet; 2006 Jul; 15(14):2216-24. PubMed ID: 16760222
[TBL] [Abstract][Full Text] [Related]
8. HNF1A：From Monogenic Diabetes to Type 2 Diabetes and Gestational Diabetes Mellitus.
Li LM; Jiang BG; Sun LL
Front Endocrinol (Lausanne); 2022; 13():829565. PubMed ID: 35299962
[TBL] [Abstract][Full Text] [Related]
9. Low frequency variants in the exons only encoding isoform A of HNF1A do not contribute to susceptibility to type 2 diabetes.
Jafar-Mohammadi B; Groves CJ; Owen KR; Frayling TM; Hattersley AT; McCarthy MI; Gloyn AL
PLoS One; 2009 Aug; 4(8):e6615. PubMed ID: 19672314
[TBL] [Abstract][Full Text] [Related]
10. 3D chromatin maps of the human pancreas reveal lineage-specific regulatory architecture of T2D risk.
Su C; Gao L; May CL; Pippin JA; Boehm K; Lee M; Liu C; Pahl MC; Golson ML; Naji A; ; Grant SFA; Wells AD; Kaestner KH
Cell Metab; 2022 Sep; 34(9):1394-1409.e4. PubMed ID: 36070683
[TBL] [Abstract][Full Text] [Related]
11. Integration of single-cell multiomic measurements across disease states with genetics identifies mechanisms of beta cell dysfunction in type 2 diabetes.
Wang G; Chiou J; Zeng C; Miller M; Matta I; Han JY; Kadakia N; Okino ML; Beebe E; Mallick M; Camunas-Soler J; Dos Santos T; Dai XQ; Ellis C; Hang Y; Kim SK; MacDonald PE; Kandeel FR; Preissl S; Gaulton KJ; Sander M
bioRxiv; 2023 Jan; ():. PubMed ID: 36711922
[TBL] [Abstract][Full Text] [Related]
12. INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cells.
Bonner C; Bacon S; Concannon CG; Rizvi SR; Baquié M; Farrelly AM; Kilbride SM; Dussmann H; Ward MW; Boulanger CM; Wollheim CB; Graf R; Byrne MM; Prehn JH
Diabetes; 2010 Nov; 59(11):2799-808. PubMed ID: 20682686
[TBL] [Abstract][Full Text] [Related]
13. Metabolic profiling in Maturity-onset diabetes of the young (MODY) and young onset type 2 diabetes fails to detect robust urinary biomarkers.
Gloyn AL; Faber JH; Malmodin D; Thanabalasingham G; Lam F; Ueland PM; McCarthy MI; Owen KR; Baunsgaard D
PLoS One; 2012; 7(7):e40962. PubMed ID: 22859960
[TBL] [Abstract][Full Text] [Related]
14. Genetic regulatory signatures underlying islet gene expression and type 2 diabetes.
Varshney A; Scott LJ; Welch RP; Erdos MR; Chines PS; Narisu N; Albanus RD; Orchard P; Wolford BN; Kursawe R; Vadlamudi S; Cannon ME; Didion JP; Hensley J; Kirilusha A; ; Bonnycastle LL; Taylor DL; Watanabe R; Mohlke KL; Boehnke M; Collins FS; Parker SC; Stitzel ML
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2301-2306. PubMed ID: 28193859
[TBL] [Abstract][Full Text] [Related]
15. Systems biology of the IMIDIA biobank from organ donors and pancreatectomised patients defines a novel transcriptomic signature of islets from individuals with type 2 diabetes.
Solimena M; Schulte AM; Marselli L; Ehehalt F; Richter D; Kleeberg M; Mziaut H; Knoch KP; Parnis J; Bugliani M; Siddiq A; Jörns A; Burdet F; Liechti R; Suleiman M; Margerie D; Syed F; Distler M; Grützmann R; Petretto E; Moreno-Moral A; Wegbrod C; Sönmez A; Pfriem K; Friedrich A; Meinel J; Wollheim CB; Baretton GB; Scharfmann R; Nogoceke E; Bonifacio E; Sturm D; Meyer-Puttlitz B; Boggi U; Saeger HD; Filipponi F; Lesche M; Meda P; Dahl A; Wigger L; Xenarios I; Falchi M; Thorens B; Weitz J; Bokvist K; Lenzen S; Rutter GA; Froguel P; von Bülow M; Ibberson M; Marchetti P
Diabetologia; 2018 Mar; 61(3):641-657. PubMed ID: 29185012
[TBL] [Abstract][Full Text] [Related]
16. Novel insights into genetics and clinics of the HNF1A-MODY.
Valkovicova T; Skopkova M; Stanik J; Gasperikova D
Endocr Regul; 2019 Apr; 53(2):110-134. PubMed ID: 31517624
[TBL] [Abstract][Full Text] [Related]
17. HNF1α controls glucagon secretion in pancreatic α-cells through modulation of SGLT1.
Sato Y; Rahman MM; Haneda M; Tsuyama T; Mizumoto T; Yoshizawa T; Kitamura T; Gonzalez FJ; Yamamura KI; Yamagata K
Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165898. PubMed ID: 32711050
[TBL] [Abstract][Full Text] [Related]
18. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
[TBL] [Abstract][Full Text] [Related]
19. Defective functions of HNF1A variants on BCL2L1 transactivation and beta-cell growth.
Sujjitjoon J; Charoensuk C; Thanyaphon T; Kooptiwut S; Thamtarana PJ; Tangjittipokin W; Chongjaroen N; Chanprasert C; Abubakar Z; Lapbenjakul S; Yenchitsomanus PT; Plengvidhya N
Biochem Biophys Res Commun; 2020 Aug; 529(3):826-833. PubMed ID: 32684311
[TBL] [Abstract][Full Text] [Related]
20. Reduced calcium levels and accumulation of abnormal insulin granules in stem cell models of HNF1A deficiency.
González BJ; Zhao H; Niu J; Williams DJ; Lee J; Goulbourne CN; Xing Y; Wang Y; Oberholzer J; Blumenkrantz MH; Chen X; LeDuc CA; Chung WK; Colecraft HM; Gromada J; Shen Y; Goland RS; Leibel RL; Egli D
Commun Biol; 2022 Aug; 5(1):779. PubMed ID: 35918471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
